@Jopo_dr
What is crazy, is that I can not think this is at all common. I mean, how often do 7 consultants agree on *anything*, let alone something so controversial. If all consultants in dept say - 'this is really unusual, we are worried', this is already a 1 in a million event..
Whatever you think of
@VPrasadMDMPH
, he certainly knows how to take apart a study. I do think community masking has a small effect on community transmission, but why CDC are promoting this is so odd. I can't imagine ECDC, UKHSA, NCID (SA) or others doing anything like this.
What happened to science?
When the pandemic ends, and people have no faith in public health, it would be wrong to blame Joe Rogan. It's institutions like the CDC and our leaders who push bad info masquerading as science.
My analysis:
The PA issue is complex and multifaceted, but the idea that NHSE is saying I as a secondary care doc holding MRCP *cannot* see undifferentiated patients but those with 1-2yrs uni course can does not follow much logic.
New MR paper out on the risk of sepsis associated with iron status - short answer: more iron = more sepsis. We think this probably has implications for iron supplementation programmes in healthy adults (i.e. be conscious of risks) 1/n
1/ We have a new preprint out that provides promising evidence using genetic data that IL-6 inhibition (e.g. with drugs like tocilizumab) might work in sepsis, like it did in COVID-19.
We think this deserves a randomised trial:
I've created another short blog on the geography of COVID-19 in the UK. It's here: , but there is a short thread attached. Short answer: It's everywhere, and has been for a while (probably) (1/n)
@VirusesImmunity
@WilenLab
@chennifer_jen
@StephanieEisen
Interesting data. Some data that NSAIDs beneficial in mild infection (e.g pyelonephritis) but we and others shown NSAIDS associated with harm in pneumonia (wasn't what we were looking for but hey-ho)
.
1/ Based on the inspiring work from
@TaurVil
@LB_Barreiro
on the Black Death and evolution at immune loci, we have a new short report out, looking at one of the loci they identified in more detail! It is SUPER interesting (I promise)
Wow. I just managed to log on to editorial manager first time without resetting a password. Incredible. Probably - no - unquestionably my greatest achievement in academia.
New paper out that looks at the duration of symptoms for cellulitis - a suprisingly commonly asked question by patients and clinicians!
We extracted data from a recent RCT that tested adjunctive clindamycin and recorded a number of measures:
"The term AGP has neither face validity nor construct validity. We should focus on the risk in plain sight: caring for patients with COVID-19 who are coughing."
New paper arguing to bury the term 'aerosol generating procedure'.
Great work from Bristol team.
Nice to see our paper out and getting Topol'ed! Of course, this is a small (n = 66), unblinded, cohort which has limitations, and our main finding is that symptoms and quality of life metrics are certainly not made worse by vaccination in patients with long COVID. 1/n
First prospective report (preprint) of vaccines helping people with
#LongCovid
(LC): 44 LC individuals vs 22 matched, unvaccinated controls with 8 months follow-up. A significant increase of symptom resolution (23 v 15%) in this small study.
h/t
@CovidTooo
On service. I am increasingly of opinion that tests with a turn around time of > 5 days have almost zero clinical utility in inpatients. Probably negative as increase length of stay waiting for them. All they do is turn up in my inbox after discharge.
Controversial take: pharmacists are very sensible and I doubt if well regulated, there would be a notable increase in AMR with sensible guidance and clear limitations on indication. Hospital prescribing (by doctors, largely) of broad spectrum antimicrobials is bigger issue.
We have a new short preprint up examining two commonly used non-linear Mendelian randomisation approaches using negative controls in the wake of recent concerns about their performance
Clinical research careers - at my stage - are a minefield. Few jobs, very few specific funding posts (NIHR Advanced Fellow, MRC Clin Scientist), matching up CCT date with fellowship, real chance of bouncing out. Oh, and I'm still a registrar. I qualified in 2012. Years to go.
Fix clinician research careers:
"There is an urgent problem with the current mechanisms for clinician scientists to effectively develop and undertake their research careers. The Govt must rectify this to improve the ability of the NHS to deliver more effective health care."
*every single* retweet of this is negative. I've actually never seen a ratio this high. Normally one positive comment. Kinda remarkable. Shows strength of feeling (of internet denizens at least) on this issue.
🧵The updated
#GoodMedicalPractice2024
uses the term ‘medical professionals’ as a collective term for doctors, physician associates (PAs) and anaesthesia associates (AAs), rather than listing out each individual role for every reference. We haven't removed doctors from the…
@SmallRedOne
@BallouxFrancois
@skepticalzebra
I think I disagree Catherine. I think people should be judged on their content, not their credentials. Whether they have a PhD / medical degree is kind of irrelevant. Look at people like
@JamesWard73
and
@BristOliver
- fantastic content, no prof experience in ID epi (I think!)
@ThatRyanChap
I honestly have no idea what will happen in Aus. It's actually plausible they will have a worse time than W Europe. To get hit with delta with no pre-existing immunity is a pretty tough gig. I hope the vaccines come soon. Delta is a firecracker.
With dozens of researchers at Yale, Stanford, Berkeley and IPA and several other organizations, we ran a cluster randomized trial involving almost 350,000 people and 600 villages in Bangladesh to assess the impact of community masking on COVID.
Symptoms: Unlike radiology/lung function - symptoms were VERY common across all severities of COVID-19 - this is
#LongCovid
. 74% of patients had >=1 symptom at follow up. Breathlessness, insomnia, and excessive fatigue were very common.
@EddCarlton
so many questions...!? I would 100% be rather tried in a criminal court for any actions I had done than in some GMC Kangaroo court - they are awful.
Our recent piece in
@bmj_latest
around recent fluoroquinolone restrictions from the MHRA - we need more information on why restrictions were made! We cannot stop using this class of drugs without knowing why.
All we ask for is the data.
Another day,another case
Without opening the case,guess where this doctor has qualified from. And ethnicity
(H/T
@nysuri
for flagging)
@gmcuk
referrals-weaponised by
#NHS
to destroy lives
It’s not the law, it’s application of it- with prejudice
#IMG
I should actually tweet the paper -
Headlines: CPAP not an AGP, HFNO v likely not, cough bad. (caveats, as always, in the paper!)
Thanks to all who volunteered for CPAP (esp
@Hamilton_09
- who tolerated it well by all accounts). Thanks, Sis!
Really tough day yesterday. After what I thought was an OK performance last year I was expecting a callback to be the nursery's father Christmas. Turns out I have been replaced by a younger model!! Had prepared costume already. Thinking of filing formal complaint.
More broad spectrum abx use when you use a biofire rapid PCR panel in pneumonia
Not a stewardship win in adults
and ~£100-150 a pop...
Not much hint of any other benefit
I'm skeptical of any great benefit of these multiplex panels (there will be some)
A step forward in the treatment of CAP!
🔥CAPNOR RCT🔥
Routine deployment of PCR testing for lower respiratory tract pathogens led to faster and more targeted microbial treatment for patients with suspected CAP
#IDXposts
Really glad HEE have sorted out the major issues in medical training such as v low levels satisfaction, greatest pressures in NHS ever, concern re academic training pathways, CESR, non medical practitioners and therefore can find the time to write this helpful guidance on dating.
i have never seen a bigger effect in my life and I think i believe it, seeing PICU last week. This will make a dramatic difference next winter in places where it is used.
@BallouxFrancois
People think immunosuppression is bad for infection, but it's not nearly as bad as other comorbidities (generally). We have a paper under review that looks at outcomes from bloodstream infection in the transplant population - very interesting, and not what you might think...
Have you had an antibody test? Were you convinced you had COVID-19 - but it was negative? Our new study might help. In this study (again - at
@NorthBristolNHS
- we look at the performance of one of the commercial, PHE approved Abbott Architect tests 1/n
Wow. I feel very unsure about this as a hospital infection person. The studies I have seen have all been heavily biased by confounding by indication. FQs are great drugs with bad adverse event profiles. I certainly feel comfortable using them in severe infection.
From today, fluoroquinolone antibiotics must only be administered when no other antibiotics are appropriate for use -
@MHRAgovuk
This is going need a bit of an updating of antibiotics guidelines & disseminating to all parts of
#NHS
incl
#TeamGP
.
Metadata is nearly always more useful than data. I will die on this hill. The fact that you did a blood test at 2am tells me more than the result. If the senior nurses is worried. Etc etc. Time and time again. There is good empirical data on this...
@apsmunro
@EpiEllie
Very sad to see. It's not even a compelling argument, even if one agreed with the sentiment. "Potable water - my grandparents didn't have it - so its not important".
We have a new paper: looking at the role of aspirin in preventing cardiac events after pneumonia. A collaboration between
@capcbristol
,
@BristolARU
and
@UEMSHealthStats
. Firstly, it is recognised that pneumonia leads to stroke and MI
@CollignonPeter
Peter, I'm not sure that reflects the underlying data well.
@doctimcook
has reviewed; rates in HCW were vastly higher than community (at least in UK) and not in the AGP delivering specialities. Other reviews too. Our local data from
@infection_doc
also
John Turnidge making it clear that
@BradSpellberg
has had the largest effect on current antibiotic prescribing practice by his enthusiasm and effort. Hats off Brad!!
#ECCMID2023
New (short) paper out - A Bayesian re-analysis of the convalescent plasma (CP) arm of RECOVERY with
@DrToddLee
@karlahemming
@rjlilford
and
@DavidT_Arnold
.
Key question: Is CP futile in hospitalised patients with COVID-19? 🧵 below...
@VPrasadMDMPH
I have actually shifted my position on N95's over the pandemic; as the evidence has shifted, i think it is pretty clear that medical staff caring for COVID-19 patients should wear them (and paramedics etc). But masking a 4 year old is not going to have anywhere near same tradeoff
Genuine q for ppl more concerned about schools being closed than covid: are you aware mandatory schooling is barely a century old in this country?
Maybe ur all grandparents had highschool, but what about ur great-grandparents?
Yes, education is important. But it’s a pandemic!
We looked at fluoroquinolone prescribing in the UK over last 5 years as MHRA claim in 2023 update "no change in FQ prescribing". We find using
@theosanderson
and
@openprescribing
's data that.. this..isn't really true. 5% drop per year in primary care..
This ventilation thing ALWAYS gets me. It's a hard problem. It's not an easy fix. The easy fixes have already been done. I think HEPA might work (not proven), but "improving ventilation" has either happened, is very difficult, or is very costly / time consuming.
Given they're already widely using the perceived low-cost/harm measured such as vax passports, masks, and apparently ventilation, it will be interesting to watch the policy response to any COVID surges across Europe.
@ThatRyanChap
It is so frustrating..of course they work, but the effect size people think they have is clearly inflated dramatically. Regardless of your views on them, decisions re them will not alter the pandemic in the UK in any meaningful fashion in my view.
How can we get 14,000 randomised for another (null) Vit D study yet it's taken us years to even ask the most basic questions in infection ever? I have never drunk the Vit D Kool Aid but it appears to be popular
🆕️✨️VITAL RCT✨️🆕️
@CIDJournal
In older adults not selected for vitamin D deficiency,supplemental vitamin D did NOT lower upper respiratory infection risk overall. Whether effects differ in subgroups requires further study.
#idxposts
#MedEd
QoL and symptom burden are massive (
#LongCovid
). We need effective strategies to manage these impacts of COVID-19 - on people - perhaps rather than performing lots of testing on patients who have had mild COVID-19.
@drmattuk
@pash22
Matt, please let me know if you want any help with coding / spatial plotting etc. Have a bit of experience in R and geographic data with mixed models etc. Thanks for collating this important data.
The latest issue of
@ThoraxBMJ
features art I designed for a comic explaining the AERATOR studies (discussed inside) to make the findings more accessible. Thank you to
@DavidT_Arnold
et al for commissioning the comic:
#graphicMedicine
#scicomm
Had a paper rejected this am after 2 fair peer reviews. Feel surprisingly positive - manuscript will be improved by comments, and it probably wasn't high enough quality for the journal I was submitting too. Feel like I should feel more grumpy... But the comments were fair!
Well done to the research teams, but also my baby son who despite waking me up just now is in this landmark study that will change paediatrics! (He got nirsevimab!)
One of the INCREDIBLY frustrating things about working as a clinical academic is leaving employer A (for literally 3/12), then rejoining and acting as if they've never heard of me. You literally gave me a degree. 2 days ago. You emailed it to me. I don't need to prove it to you!
New manuscript out that identifies that small HDL is the major HDL component that predicts future risk of sepsis (and sepsis outcomes), and that this effect is (in part), driven by IL-6 signalling.
Outside of surgical prophylaxis, advanced HIV and haem malignancy, where does prophylaxis with abx ever work? It doesn't seem to work ever!
(Maybe acute variceal bleed?)
🔥PRECIOUS🔥
OL multifactorial RCT
in patients >=66y, prophylactic use of metoclopramide, ceftriaxone, or paracetamol in the first 4d after ischaemic stroke or ICH did not result in improvement of functional outcome or a reduction in the risk of death.
Really neat work from
@Dr_J_Underwood
@harryahmed01
@DaveGuk87
looking at the reported cause of death from BSI in Wales over >10 years
most deaths from cancer not sepsis. Higher CRP = more likely sepsis death. implications for how we do RCTs!
@ABSteward
In this multicenter trial, a single oral dose of azithromycin in women planning a vaginal delivery reduced the risk of maternal but not newborn sepsis or death.
#SMFM23
It’s taken 6 months to get from deciding to try and do this to actually doing it. Congratulations to the whole team for making it happen. Excited by the thought of results coming through.
@BristolUncover
This is literally incredible
EDs under such pressure
Randomising to a complex pleural intervention out of hours in the circumstances is amazing.
Well done to research teams involved
A few months ago we had a patient who had (at the time) the longest recorded case of COVID. We wrote this up, and it's instructive to see how persistent infection can not always lead to such severe disease - perhaps a breeding ground for variants?
6 years in the making - I will do a thread tomorrow...but all started when
@DavidT_Arnold
and me had a pint and we chatted about whether ASA might work in pneumonia, then 3 years ago , and now the RCT is open!!
Our first site opened this afternoon 🎉 ASPECT IS OFFICIALLY OPEN!
@ResearchNBT
were given Greenlight at midday and have already recruited their first 2 patients. Massive congratulations to their hard work!
#pneumonia
#research
#clinicaltrials
22,598 patients to go!
Important paper here in Nat Med. Looks like transmission of C diff rare, but asymptomatic carriage the major risk factor. Has infection control implications for sure.
@abst
A low rate of Clostridioides difficile transmission within an intensive care unit supports the effectiveness of prevention practices and highlights the greater risk to carriers of toxigenic C. difficile, according to a paper in
@NatureComms
.
This will absolutely transform care in S. Aureus. And more importantly, will give another opportunity for competition between 🦘 and 🇬🇧
The new ⚱️🏏?
£10 that UK will beat Aus in numbers by next Christmas?
@syctong
@Josh_S_Davis
@dr_michaelmarks
@DrToddLee
(🇨🇦 now play 🏏)
Great news that
@snap_trial
has launched in the UK - with 1st UK participant at
@UCLH
!
SNAP is the largest ever trial in Staphylococcus aureus bloodstream infection. We are pleased to be leading on trial management & statistical analysis in the UK.
More👉
New ESC endocarditis guidelines out. Why do they recommend with Class 1 evidence a TOE in stable patients before switch to PO therapy??? The refs are to POET trial..
By far the coolest study I've been involved in. Will do full thread later, but this involved measuring aerosol using state of the art measuring kit in out of hospital cardiac arrest - generating policy level evidence on risk of transmission.
Wow. This is stark. We must invest in primary care! Less people like me worrying about bugs in the lab. We can't improve care without focussing on where most people get their care.
This is the most striking data in the Lancet Commission on the Future of the NHS, showing the changes in the number of NHS GPs and consultants per 1,000 people between 2008-18. Note the decline in GP numbers compared to the increase in consultant numbers.
Unequivocally good news - London hospital admissions appear to have stopped rising, and possibly peaked. Raw data from
Of course, caveats around holiday season reporting (yesterdays figure seems v low), but COVID bed occupancy fits the story.
Actually, I think this is the most important paper I have read this year (yeah, I know it's Jan). Key thread explaining why sometimes simple things that seem beneficial, *might* harm patients. The whole field of "quality improvement" needs to read this paper. Twice.
Thread to discuss our new RCT (ELAIA-1) appearing in
@bmj_latest
that showed some unexpected results in the world of electronic alerts for acute kidney injury.
Our Bayesian re-analysis of the RECOVERY trial with
@DrToddLee
@karlahemming
@rjlilford
@DavidT_Arnold
is out in IJID.
Now we know REGN-CoV-2 works, we consider whether convalescent plasma works (it probably does), and whether the null result is fair.
I have an incredibly supportive department at university and hospital level, have been lucky in traditional metrics (grants papers etc) and it is still *very* challenging to do this job. Needs to change.
There is a crisis in clinical academia in the UK. We talk of the need to expand medical schools, embed research into the NHS to improve care, & the importance of a vibrant life sciences sector for the economy of the UK, & yet we seem unable to tackle the underlying issues 1/9
Amazing. Even in complex intra abdominal infection shorter is better. Although we kind of know abx in appendicitis are arguably anyway. But keep it short. My career is in danger at current rate - 48h abx seems to work for nearly everything!
🔥APPIC study🔥
2 days of IV antibiotics for pts with complex appendicitis post laparoscopic appendicectomy is non-inferior to 5 days in terms of infectious complications & mortality within 90d, based on a non-inferiority margin of 7·5%
#shorterisbetter
I appreciate trial regulations, but i am on page 6 of writing a CTIMP protocol and ...I mean...there is a BIG difference between a novel product requiring intense review and a widely used product for a subtly different indication. How much time is wasted on this stuff.
@ABsteward
@BradSpellberg
@ASPphysician
@DrToddLee
Sorry. Are they serious. So 50% of HAP should get 2 antipseudomonals + linezolid??? Do they realise that most people with HAP have had prior IV abx.. at least in my pop? Am I misreading this???
Sort of crazy that you can WGS a human and find a disease causing variant about 4 times quicker than we can tell you if you have bloodstream infection and whether the bug is resistant to augmentin
Quickly diagnosing a critically ill patient using whole genome sequencing is challenging, but we have found a solution! Published today in
@NatureBiotech
, we detail the technical methods to dx genetic disease in < 8 hours using
@nanopore
sequencing.
1/8
Massive effect size - using the new regulatory endpoint. I think hard to not favour (co-)amox + clari as first line for CAP now, rather than say a floroquinolone or co-amox monotherapy. Endpoint seems meaningful, and more alive and out of hosp at d90.
🔥ACCESS RCT🔥
@LancetRespirMed
The addition of clarithromycin to standard of care* to adults in the hospital with CAP who had systemic inflammatory response syndrome** enhances early clinical response & attenuates the inflammatory burden of CAP
#idxposts
I honestly don't know how you find out before I do
It's kind of incredible
@ABsteward
. Paper below. Immunosuppression a complex beast in infection. Difficult to draw causation from obs data (and transplant patients v different from non, but interesting...)
🆕💥💥
@gushamilton
Organ transplantation is associated with a near halving of short term mortality in BSI including a cohort matched for comorbidities infective pathogen & focus
Steroid usage is associated with ⬆️ mortality regardless of transplant status
@Dr_Done_
Are NE likely doctors? Genuine don't know but suspect wide spread of professions and most multifactorial with multi professional input? Would love to see data!
We have a number of ACFs in Bristol including in Infectious Disease and Medical Microbiology. Really happy to chat to any potential applicants.
Huge range of ID research from vaccines to pharmacokinetics to AMR to epi. Please apply!
Was going to tweet about our article, but Bassam beat me to it. No association between time-to-positivity of BC and outcomes. V interesting, given we think that pathogen load is a key driver of outcomes in other infections (e.g. COVID-19). This is probably because..
🆕💥Analysis Data from RAPIDO RCT
Time to positivity is not associated with mortality, except in Candida spp (longer times associated with worse outcomes), and possibly in Streptococci (shorter times associated with worse outcomes)
#IDTwitter
#medtwitter
No hospitalisations after single dose AZ. Great news. Suggests JCVI right!
Well done all especially local Bristol people involved
@LazarusRajeka
@adamhfinn
Our new preprint on the efficacy of a single dose of the Oxford/AZ ChAdOx1 nCoV-19
#vaccine
-76% efficacy against symptomatic infection from day 22 to day 90 post vaccination in 17,177 trial participants in UK, Brazil and S Africa:
This really is incredible work
This trial will answer fundamental questions about the management of SAB - and will be appropriately powered
A true global effort
UK still waiting to start !
The
@snap_trial
has hit 1000 randomised participants today!
The DSMC meets tommorrow for the first 500 outcomes.
Recruitment to end of June 2023 below.
Thanks to all the participants, site investigators, and everyone else involved!!
@Josh_S_Davis
@DrToddLee
I and others provide some comment about the
@MHRApress
decision to essentially ban fluoroquinolones. Leaves infection doctors in a pickle.
Thanks
@bmj_latest
for the opportunity to comment. We have more on this soon.
Credit where credit is due, have just had 2 excellent, detailed reviews on a paper submitted only twelve days ago. Not all positive comments (!) but amazing experience and feels breath of fresh air...